A multicenter retrospective study on evaluation of predicative factors for positive biopsy of prostate cancer in real-world setting

References

• Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version). Chin J Cancer Res. 2019;31:67–83.
   PubMedGoogle Scholar
• Yu W, Zhou L. Early diagnosis of prostate cancer from the perspective of Chinese physicians. J Cancer. 2020;11(11):3264–3273.
   PubMed Web of Science ®Google Scholar
• Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019;10(2):63–89.
   PubMedGoogle Scholar
• Ye D, Zhu Y. Epidemiology of prostate cancer in China: an overview and clinical implication. Zhonghua Wai Ke Za Zhi. 2015;53(4):249–252.
   PubMedGoogle Scholar
• Prostate Cancer Working Group of Genitourinary Cancer Committee in Chinese Anti-Cancer Association. Consensus of prostate cancer screening. Zhonghua Wai Ke Za Zhi. 2017;55:340–342.
   PubMedGoogle Scholar
• Feng R-M, Zong Y-N, Cao S-M, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. 2019;39(1):22.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wu S, Guo L-R, et al. Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China. Asian J Androl. 2009;11(1):9–13.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang J, Guo B, et al. Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China. Oncotarget. 2018;9(1):428–441.
   PubMedGoogle Scholar
• van den Bergh R, Loeb S, Roobol MJ. Impact of early diagnosis of prostate cancer on survival outcomes. Eur Urol Focus. 2015;1(2):137–146.
   PubMedGoogle Scholar
• Hamdy FC. Prognostic and predictive factors in prostate cancer. Cancer Treat Rev. 2001;27(3):143–151.
   PubMed Web of Science ®Google Scholar
• Jang JY, Kim YS. Is prostate biopsy essential to diagnose prostate cancer in the older patient with extremely high prostate-specific antigen? Korean J Urol. 2012;53(2):82–86.
   PubMedGoogle Scholar
• Fang D, Ren D, Zhao C, et al. Prevalence and risk factors of prostate cancer in chinese men with PSA 4-10 ng/mL who underwent TRUS-guided prostate biopsy: the utilization of PAMD score. Biomed Res Int. 2015;2015:596797.
   PubMed Web of Science ®Google Scholar
• Descotes J-L. Diagnosis of prostate cancer. Asian J Urol. 2019;6(2):129–136.
   PubMed Web of Science ®Google Scholar
• Tao T, Shen D, Yuan L, et al. Establishing a novel prediction model for improving the positive rate of prostate biopsy. Transl Androl Urol. 2020;9(2):574–582.
   PubMed Web of Science ®Google Scholar
• Liu J, Dong B, Qu W, et al. Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone. Sci Rep. 2020;10(1):5157.
   PubMed Web of Science ®Google Scholar
• Demirel HC, Davis JW. Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions. Turk J Urol. 2018;44(2):93–102.
   PubMed Web of Science ®Google Scholar
• Wade J, Rosario DJ, Howson J, et al. Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial. BMC Health Serv Res. 2015;15:80.
   PubMed Web of Science ®Google Scholar
• Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876–892.
   PubMed Web of Science ®Google Scholar
• Groarke A, Curtis R, Walsh DMJ, et al. What predicts emotional response in men awaiting prostate biopsy? BMC Urol. 2018;18(1):27.
   PubMedGoogle Scholar
• Niu X, Li J, Das SK, et al. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone. BMC Med Imaging. 2017;17(1):11.
   PubMedGoogle Scholar
• Moore CM, Giganti F, Albertsen P, et al. Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations-a report of a European School of Oncology Task Force. Eur Urol. 2017;71(4):648–655.
   PubMed Web of Science ®Google Scholar
• Tan N, Margolis DJ, Lu DY, et al. Characteristics of detected and missed prostate cancer foci on 3-T multiparametric MRI using an endorectal coil correlated with whole-mount thin-section histopathology. Am J Roentgenol. 2015;205(1):W87–W92.
   PubMed Web of Science ®Google Scholar
• Mj R, Ew S, R K, et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer [Internet]. European urology. 2010. [cited 2020 Sep 10]. Available from: https://pubmed.ncbi.nlm.nih.gov/19733959/.
   Google Scholar
• Roobol MJ, van Vugt HA, Loeb S, et al. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators. Eur Urol. 2012;61(3):577–583.
   PubMed Web of Science ®Google Scholar
• Ankerst DP, Hoefler J, Bock S, et al. Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology. 2014;83(6):1362–1367.
   PubMed Web of Science ®Google Scholar
• Rk N, A T, Lh K, et al. Assessing individual risk for prostate cancer [Internet]. J Clin Oncol. 2007. [cited 2020 Sep 10]. Available from: https://pubmed.ncbi.nlm.nih.gov/17704405/.
   Google Scholar
• Chiu PK, Roobol MJ, Nieboer D, et al. Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population. Prostate Cancer Prostatic Dis. 2017;20(1):99–104.
   PubMed Web of Science ®Google Scholar
• Jia Y, Zhu L-Y, Xian Y-X, et al. Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases. World J Surg Oncol. 2017;15(1):165.
   PubMedGoogle Scholar
• Lo KL, Chui KL, Leung CH, et al. Outcomes of transperineal and transrectal ultrasound-guided prostate biopsy. Hong Kong Med J. 2019;25(3):209–215.
   PubMed Web of Science ®Google Scholar
• Huang G-L, Kang C-H, Lee W-C, et al. Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches – a single center preliminary study. BMC Urol. 2019;19(1):101.
   PubMed Web of Science ®Google Scholar
• Elwenspoek MMC, Sheppard AL, McInnes MDF, et al. Comparison of multiparametric magnetic resonance imaging and targeted biopsy with systematic biopsy alone for the diagnosis of prostate cancer: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(8):e198427.
   PubMed Web of Science ®Google Scholar
• Huang S, Reeves F, Preece J, et al. Significant impact of transperineal template biopsy of the prostate at a single tertiary institution. Urol Ann. 2015;7(4):428–432.
   PubMed Web of Science ®Google Scholar
• Ong WL, Weerakoon M, Huang S, et al. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience. BJU Int. 2015;116(4):568–576.
   PubMed Web of Science ®Google Scholar
• Tobiume M, Yamada Y, Nakamura K, et al. Retrospective study comparing six- and twelve-core prostate biopsy in detection of prostate cancer . Int Braz J Urol. 2008;34(1):9–14.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Roehrborn CG. Using biopsy to detect prostate cancer. Rev Urol. 2008;10(4):262–280.
   PubMedGoogle Scholar
• Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997;157(1):199–202. discussion 202–203.
   PubMed Web of Science ®Google Scholar
• Naughton CK, Miller DC, Mager DE, et al. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol. 2000;164(2):388–392.
   PubMed Web of Science ®Google Scholar
• Zhang K, Bangma CH, Roobol MJ. Prostate cancer screening in Europe and Asia. Asian J Urol. 2017;4(2):86–95.
   PubMed Web of Science ®Google Scholar
• Egawa S, Matsumoto K, Yoshida K, et al. Results of transrectal ultrasound-guided biopsies and clinical significance of Japanese prostate cancer. Jpn J Clin Oncol. 1998;28(11):666–672.
   PubMed Web of Science ®Google Scholar
• Shim HB, Lee SE, Park HK, et al. Accuracy of a high prostate-specific antigen level for prostate cancer diagnosis upon initial biopsy in Korean men. Yonsei Med J. 2007;48(4):678–683.
   PubMed Web of Science ®Google Scholar
• Lam S, A K, M A, et al. The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy. Br J Cancer. 2017;116:1159–1165.
   PubMed Web of Science ®Google Scholar
• Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–822.
   PubMed Web of Science ®Google Scholar
• Taitt HE. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health. 2018;12(6):1807–1823.
   PubMed Web of Science ®Google Scholar
• Ujike T, Uemura M, Kawashima A, et al. A novel model to predict positive prostate biopsy based on serum androgen level. Endocrine-Related Cancer. 2018(1);25:59–67.
   PubMed Web of Science ®Google Scholar